Interleukin News and Research

RSS

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers reviewed the effectiveness of cannabidiol in treating COVID-19 inflammatory-related symptoms.

28 Jul 2022

Highly specialized T cells remain in blood 20 months after COVID-19

researchers analyze T-cell reactivity following recovery from COVID-19.

27 Jul 2022

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically and effectively bind to the SARS-CoV-2 genome target to inhibit SARS-CoV-2 replication.

27 Jul 2022

Scientists explore SARS-CoV-2 spike protein and platelet-activating factor

Researchers assessed the association between platelet-activating factor (PAF) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein.

25 Jul 2022

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

A multicenter, randomized, placebo-controlled phase 2a clinical trial has recently been conducted to evaluate the efficacy of a nanotherapeutic compound OP-101 in treating severe COVID-19 patients.

21 Jul 2022

Associations between whole blood viscosity and SARS-CoV-2-linked death

Researchers depicted the link between COVID-19-associated mortality and whole blood viscosity (WBV).

21 Jul 2022

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Researchers determined whether the incidence of new diabetes mellitus (DM) and cardiovascular diseases (CVDs) increases in a year among those recovering from COVID-19.

21 Jul 2022

Is monkeypox a global public-health emergency?

A summary of available knowledge on the monkeypox virus including pathogenicity, risk to the human population, and strategies that can help limit its spread.

20 Jul 2022

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Researchers assessed the association between natural killer cell dysfunction and COVID-19 disease severity.

20 Jul 2022

Analyzing whether SARS-CoV-2 nucleocapsid and spike proteins stimulate dendritic or γδ T cells

Researchers showed that the SARS-CoV-2 nucleocapsid (N) and spike (S) proteins did not activate γδ T cells and dendritic cells (DCs).

18 Jul 2022

Study shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infection

Researchers reported on the benefit of immunity developed by previous SARS-CoV-2 infection for overcoming the age-associated decline in COVID-19 vaccine effectiveness.

18 Jul 2022

Novel nanoligomer approach to treat severe COVID-19

Researchers discuss the biodistribution and safety of a novel nanoligomer SBCoV207, which was used to targeted miR-2392 in a murine model.

17 Jul 2022

Evidence for a specific anti-inflammatory metabolic signature in long-COVID

A recent research paper posted to the medRxiv* preprint server illustrated anti-inflammatory and hypo-metabolic fingerprints in long coronavirus disease (COVID) syndrome (LCS) using pan-omics plasma assessments.

15 Jul 2022

Breastfeeding provides an immune boost that helps infants to fight off infectious diseases

When infants breastfeed, they receive an immune boost that helps them fight off infectious diseases, according to recent research from Binghamton University Associate Professor of Anthropology Katherine Wander.

12 Jul 2022

Does COVID-19 cause hair loss?

A new study discusses hair loss as a result of COVID-19.

12 Jul 2022

Study reveals sex-based differences in the clinical outcomes of COVID-19 in the US

Researchers investigated sex-based differences among COVID-19 patients in the United States.

11 Jul 2022

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

Interleukin News and Research

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Highly specialized T cells remain in blood 20 months after COVID-19

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Scientists explore SARS-CoV-2 spike protein and platelet-activating factor

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

Associations between whole blood viscosity and SARS-CoV-2-linked death

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Is monkeypox a global public-health emergency?

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Analyzing whether SARS-CoV-2 nucleocapsid and spike proteins stimulate dendritic or γδ T cells

Study shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infection

Novel nanoligomer approach to treat severe COVID-19

Evidence for a specific anti-inflammatory metabolic signature in long-COVID

Breastfeeding provides an immune boost that helps infants to fight off infectious diseases

Does COVID-19 cause hair loss?

Study reveals sex-based differences in the clinical outcomes of COVID-19 in the US

Experimental model reveals possible causes and treatments for long-COVID

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

Human milk immune activity may both lower and increase infants’ infectious disease risk

Scientists identify molecules promoting plant immunity

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News